October 24, 2011; Hyderabad, India: GVK Biosciences (GVK BIO), Asia’s leading drug discovery research
& development organization, announced today that Astellas Pharma Inc. (Tokyo:4503, “Astellas”)
extended and renewed its license to the GVK BIO SAR Databases (GOSTAR).
GOSTAR (GVK BIO Online Structure Activity Relationship (SAR) Database) is an online scientific database
product of GVK BIO. It integrates information on compounds from discovery & development stages and
marketed drugs. Information provided includes SAR, ADME, toxicity, preclinical, clinical and structural
data for over 5.1 million compounds and 16.7 million SAR points.
Sreeni Devidas, Vice President, Sales & Marketing, Informatics, at GVK BIO said, “We are excited that
Astellas has decided to extend the license to the GOSTAR database. The GOSTAR database is becoming
an indispensible tool for scientists in drug discovery. Several publications that have used the GOSTAR
data validate the utility of this product.”
Informatics at GVK BIO
The Informatics division is responsible for analyzing data to transform chemical / biological patterns into
knowledge. Informatics offers Custom Curation, Cheminformatics and Bioinformatics services to global
clients. It also licenses and sells databases to Biotech and Pharma companies.
About GVK Biosciences
GVK Biosciences (GVK BIO) is Asia’s leading Discovery Research and Development organization. GVK BIO
provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our
discovery services consist of Chemistry, Biology and Informatics; the development services include
Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of more than 150
customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-sciences
companies and leading academic institutions. Please visit us at www.gvkbio.com to know more.
About Astellas
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the
health of people around the world through the provision of innovative and reliable pharmaceutical
products. Astellas has approximately 16,000 employees worldwide. The organization is committed to
becoming a global category leader in urology, immunology & infectious diseases, neuroscience, DM
complications & metabolic diseases and oncology. For more information on Astellas Pharma Inc., please
visit our website at http://www.astellas.com/en.
For any further information, please contact:
Sreeni Devidas
Vice President – Sales & Marketing, Informatics
GVK Biosciences Private Limited
Columbia, MD 21045
T 001-443-838-6260
E sreeni.devidas@gvkbio.com
W www.gvkbio.com
Sharada Alvakonda
Dy General Manager – Corporate
Communications
GVK Biosciences Private Limited
T 0044-743-8307768
E sharada@gvkbio.com